Testosterone Variation Across the Menstrual Cycle in Women
Testosterone levels in women show modest but statistically significant variation across the menstrual cycle, with a small peak at midcycle, though this variation is clinically minor and often overshadowed by day-to-day fluctuations and between-woman variability. 1
Magnitude of Variation
The Endocrine Society Clinical Practice Guideline (2014) provides the most authoritative framework on this topic. Multiple studies using accurate mass spectrometry methods have consistently demonstrated:
- A small, statistically significant increase in testosterone occurs at midcycle (around ovulation) 1
- Studies examining 25-161 women across follicular, midcycle, and luteal phases all showed this midcycle rise 1
- The variation is modest - plasma testosterone is only "modestly affected by menstrual stage" 1
Recent research using highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides more specific data:
- In 21 healthy women, total testosterone peaked at midcycle at 43.6 ± 16.2 ng/dL (approximately 1.5 nmol/L), with free testosterone peaking at 15.6 ± 11.9 pg/mL 2
- In 31 women studied across the cycle, testosterone levels ranged with a reference interval of 0.30-1.69 nmol/L (8.7-48.7 ng/dL) using ID-LC-MS/MS 3, 4
- The midcycle elevation is statistically significant but not clinically relevant since day-to-day variation is higher and independent of cycle phase 3
Clinical Implications
The key clinical takeaway is that variations in testosterone throughout the female menstrual cycle are fairly insignificant for practical purposes 5. The guidelines explicitly state:
- Although it's recommended to measure testosterone in the early follicular phase, the variation is small enough that a single measurement can be interpreted using general reference ranges 6
- Several samples or timed samples with normative ranges across the cycle should be obtained for clinical reliability when precision is critical 1
- The increase in testosterone during midcycle is relatively small compared with overall variability, so reference ranges can be applied irrespective of the day in the menstrual cycle 6
Important Caveats
Between-Woman Variability
The between-woman variability is substantial and far exceeds within-cycle variation 1. This means that differences between individual women are much larger than the changes any single woman experiences across her cycle.
Day-to-Day Fluctuation
A critical finding from daily sampling studies is that day-to-day testosterone variation is higher than cycle-related changes 3. This means a single testosterone measurement might not be reflective of overall testosterone status in an individual woman.
Dihydrotestosterone (DHT) Stability
Unlike testosterone, DHT levels do not significantly change across the menstrual cycle 2, 4. This stability may make DHT a more reliable marker in certain clinical contexts.
Age-Related Decline
All androgens decline with age before menopause, necessitating age-specific reference ranges 7. Total and free testosterone decline progressively with reproductive aging 1.
Practical Recommendations
For clinical practice:
- A single testosterone measurement is generally adequate for most diagnostic purposes, as cycle variation is modest 5, 6
- When greater precision is needed (e.g., borderline values), obtain multiple samples or time samples to the early follicular phase 1
- Use mass spectrometry-based methods (LC-MS/MS) rather than direct immunoassays for accurate measurement at the low concentrations found in women 1, 2
- Interpret results using age-appropriate reference ranges, as testosterone declines significantly with age even before menopause 7